Capítulo 5. 7. b1. Otras alteraciones endocrinas. Feocromocitoma

Bibliografía
 

1.- Landsberg L, Young J B. Pheochromocytoma. In Braunwald  E, Issebalcher H J, Petersdorf R G, Wilson J D, Martin J  b, Fauci A S  Editors. Harrison ´s Principles of  Internal Medicine. 13 th   E d. New York. Mc Graw Hill. 1995.
2.- Shapiro B, Gross M D. Pheocromocytoma. Critical Care Clinics. 1991; 7: 1-21.
3.- Bravo E L, Gilford Jr R W. Pheocromocytoma. Endocrinology and Metabolism Clinics of North America. 1993; 22: 329-341.
4.- Chernow B,  Wiley S C, Zaloga G P. Terapia intensiva en Endocrinología en Shoemaker, Ayres, Grenvik, Holbrook, Thompson Editores. Tratado de Medicina Crítica y Terapia Intensiva. 2ª  Ed. Buenos Aires. Panamericana. 1994:834-838
5.- Jeevanadam V, Oz M, Shapiro B, et al. Surgical management of cardiac pheocromocytoma. Annals of Surgery. 1995; 221: 415-419.
6.- Stein P P, Black H R. A simplified diagnostic approach to pheocromocytoma. A review of the literature and report of one Institution ´s experience. Medicine. 1991; 70: 46-66.
7.- Rotker J, Oberpenning F, Scheld H H et al. Pheocromocytoma with extension into vascular structures. Ann Thorac Sur. 1996; 61: 222-224.
8.- Jaeck D, Paris F, Welsch M, et al. Primary hepatic pheochromocitoma: A second case. Surgery. 1995; 117: 586-590.
9.- Takimoto E, Ueda W. Unsuspected pheocromocytoma of the urinary bladder. Anesth Anal. 1995; 80: 1243-1244.
10.- Chen H, Doppman J L, Chorousos G P et al. Adrenocorticotropic hormone-secreting pheochromocytomas: the exception to the rule. Surgery. 1995; 118:988-995.
11.- Scott, I U. Gutterman D D. Pheochromocytoma with reversible focal cardiac dysfunction. American Heart Journal. 1995; 130: 909-910.
12.- Dabrowska B, Dabrowski A, Pruszczyc, P, Sktrobowski A, Wocial B. Heart rate variability in Pheochromocytoma. The american Journal of Cardiology. 1995; 76: 1202-1204.
13.- Huddle K R, Kalliatakis B, Skoularigis J. Pheochromocytoma associated with clinical and echocardiographic features simulating hypertrophic obstructive cardiomyopaty. Chest. 1996; 109:1394-1397.
14.- Suga K, Tsukamoto K, Nishigauchi K, et al. Iodine-123-MIBG imaging in pheochromocytoma with cardiomyopaty and pulmonary edema. The  Journal of Nuclear Medicine. 1996; 100: 1361-1364.
15.- Clinicopathologic Conference. Hypertension and Myocardial and Cerebral Infarctions. The American Journal of Medicine. 1996; 100: 357-364.
16.- Lefebvre H, Noblet C, Moore N, Wolf L M. Pseudo pheocromocytoma after multiple drug interactions involving the selectivo monoamine oxidase. Clinical Endocrinology. 1995; 42:95-99.
17.- Scully R E, Mark E J, McNeely W F, Ebeling S H. Case records of the Massachusetts General Hospital. Case 27-1996. N Eng J Med. 1996; 335: 650-655.
18.- Lenders J W M, Keiser H R, Goldstein D S, et al. Plasma metanephrines in the diagnosis of pheochromocytoma. Ann Internal Medicine. 1995; 123: 101-109.
19.- Elijovich F. Plasma metanephrines in the diagnosis of pheochromocytoma. Letter to the Editor. Ann Internal Medicine 1996; 124: 694-695.
20.- Krakoff L. Searching for pheochromocytoma: a new and better test?. Ann Internal Medicine. 1995; 123: 150-151.
21.- Peaston R T, Lennard T W J, Lai LC. Overnight excretion of Urinary catecholamines and metabolites in the detection of pheochromocytoma. J Clin Endocrinol Metab. 1996; 81: 1378-1384.
22.- Plouin P F, Bertherat J, Chatellier G, et al. Short-term effects of octeotride on blood pressure and plasma catecholamines and neuropeptide Y levels in patients with phaeochromocytoma: a placebo-controlled trial. Clinical Endocrinology. 1995; 42: 289-294.
23.- Venkata C, Ram S. Diagnosis and management of hipertensive crises. In Rippe J M, Irwin R S, Alpert J S. Fink M P Editors. Intensive Care Medicine . Second Edition. Little, Brown and Company. Boston/ Toronto/London. 1991.